期刊文献+

慢性间歇低氧大鼠血管内皮细胞生长因子变化的临床意义 被引量:2

The Endothelial Cell Function in Rats with Chronic Intermittent Hypoxia
下载PDF
导出
摘要 目的:探讨慢性间歇低氧(CIH)对大鼠体内内皮细胞功能的影响。方法:应用CIH大鼠模型,模拟阻塞性睡眠呼吸暂停低通气综合征(obstructive sleep apnea-hypopnea syndrome,OSAHS)睡眠中发生的慢性低氧、再氧合病理生理过程。将16只雄性SD大鼠分为2组(分别为CIH组和对照组),每组共8只。将CIH组大鼠放入自制的间歇低氧动物舱内,提供间歇低氧(最低吸入氧浓度6%~7%,最高吸入氧浓度20%~21%,维持时间5~7s);将对照组大鼠置于相同规格的间歇低氧动物舱内,给予空气脉冲供气。间歇低氧刺激总时间:每天8h(9:00~17:00),每周7d,持续5周,共持续35d。实验结束后(第36天),用酶联免疫吸附法(ELISA)测定大鼠血浆血管内皮细胞生长因子(VEGF)水平。结果:实验结束后(第36天),CIH组大鼠血浆中VEGF的浓度(101.08±27.55pg.mL-1)显著高于对照组(52.14±5.68pg.mL-1)(P<0.05)。结论:CIH大鼠体内存在明显内皮细胞功能障碍。 Objective:To investigate the endothelial cell dysfunction in rats with chronic intermittent hypoxia. Methods: To establish a chronic imtermittent hypoxia(CIH) animal model in rats, in order to mimic the intermittent hypoxia of obstructive sleep apnea-hypopnea syndrome (OSAHS) in humans, Sixteen healthy male SD rats were randomly assigned to two equal groups, the control group and the CIH group. The rats in CIH group were placed in an animal chamber subjected to CIH(nadir ambient oxygen concentration 6%-7% ,maximum ambient oxygen concentration 20%- 21 % ,Continuing respectively to 5-7 second) for 8 hours per day (from 9AM to 5PM) and the experimental tasted for 35 days. The rats in control group were placed in the same animal chamber without chronic imtermittent hypoxia, After the experiment,We measured the level of VEGF in plasma by EIASA. Results: VEGF in plasma in CIH group was higher than that in control group,101.08 ± 27.55 vs. 52.14 ± 5.68 pg/ml respectively (P〈0.05). Conclusion: There are endothelial dysfunction in rats with CIH.
出处 《中国临床医学》 2009年第6期821-823,共3页 Chinese Journal of Clinical Medicine
基金 上海市重点学科建设项目(编号:B115) 上海市科委基础研究重点项目(编号:07JC14012)
关键词 睡眠呼吸暂停低通气综合征 慢性间歇低氧 血管内皮生长因子 Obstructive sleep apnea-hypopnea syndrome Chronic intermittent hypoxia Vascular endothelial growth factor
  • 相关文献

参考文献15

  • 1Spector A. Review :Oxidative stress and disease[J]. Ocul Phamacol Ther, 2000,16(2) :193-201.
  • 2杨朝.阻塞性睡眠呼吸暂停综合征与高血压的关系[J].中国临床医学,2003,10(1):98-101. 被引量:9
  • 3Dart RA, Gregoire JR. Gutterman DD. et al. The association of hypertension and secondary cardiovascular disease with sleep- disordered breathing[J]. Chest, 2003,123:244- 2610.
  • 4Shahar E, Whitney CW, Redline S. et al. Sleep disordered breathing and cardiovascular disease: cross sectional results of the Sleep Heart Health Study[J]. Am J Respir Crit Care Med, 2001, 163: 19-25.
  • 5Marin JM, Carrizo SJ, Vicente E, et al. Long term cardiovascular outcomes in men with obstructive sleep apnoea hypopnoea with or without treatment wilh continuous positive airway pressure: an observational study[J]. Lancet, 2005, 365: 1046 -11153.
  • 6Kaynak D, GEksan B, Kaynak H, et al. Is there a link between the severity of sleep disordered breathing and atherosclerotic disease of the carotid arteries[J]. Eur Neurol,2003.10(5):487- 493.
  • 7Ip MS, Tse HE, Lam B, et al. Endothelial function in obstructive sleep apnea and response to treatment[J]. Am Respir Crit Care Med,2004,169:348- 353.
  • 8Nieto FJ, Herrington DM, Redline S, et al. Sleep apnea and markers of vascular endothelial function in a large community sample of older adults[J].Am Respir Crit Care Med,2004,169:354-360.
  • 9Hoshino M, Takahashi M, Aoike N, et al. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis[J]. Allery Clin Immunol, 2001, 107: 295- 301.
  • 10Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis[J]. Cell Struct Funct, 2001, 26(1): 25-35.

二级参考文献33

  • 1范洁,郭兮恒,于桂芝,钟儒德,张惠楠,黄席珍.阻塞性睡眠呼吸暂停综合征与高血压病──附240例监测报告[J].中华心血管病杂志,1995,23(5):345-347. 被引量:16
  • 2[3]Ohayon MM, Guilleminault C, Priest RG, et al. Is sleep - disordered breathing an independent risk factor for hypertension in the general population (13,057 subjects?). J Psychosom Res, 2000, 48(6): 593~601.
  • 3[4]Ip M, Chung KF, Chan KN, et al. Previously unrecognized ob structive sleep apnea inChinese subjects with essential hyperten sion. Lung, 1999, 177(6): 391~400.
  • 4[5]Isaksson H, Svanborg E. Obstructive sleep apnea syndrome in male hypertensives, refractory to drug therapy. Nocturnal automatic blood pressure measurements - an aid to diagnosis? Clin Exp Hypertens A, 1991, 13: 1195~212.
  • 5[6]Foras Js, Jomes Jv, Johnston JA, et al. Arousal and the circadi an rhythm of blood pressure. Clin Sci Mol, 1978, 55: 395~ 396.
  • 6[7]Frattola A, Parati G, Cuspidi C, et al. Prognostic value of 24 hour blood pressure variability. J Hypertens, 1993, 11: 1133~ 1137.
  • 7[8]Suzuki M, Guilleminault C, Otsuka K, et al. Blood pressure "dipping" and "non- dipping" in obstructive sleep apnea syndrome patients. Sleep, 1996, 19(5): 382~387.
  • 8[9]Peter JH, Grote L, Fus E, et al. REM- sleep -hypertension in obstructive sleep apnea. Eur J Med Res, 1995, 18: 1(3): 132~136.
  • 9[10]Noda A, Okada T, Hayashi H, et al. 24- Hour ambulatory blood pressure variability in obstructive sleep apnea syndrome. Chest, 1993, 103(5): 1343~1347.
  • 10[11]Sforza E, Lugaresi E. Determinants of the awakening rise in systemic blood pressure in obstructive sleep apnea syndrome.Blood Press, 1995, 4(4): 218~225.

共引文献8

同被引文献39

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部